BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Life Raft Group - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://liferaftgroup.org
X-WR-CALDESC:Events for The Life Raft Group
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241106T130000
DTEND;TZID=America/New_York:20241106T130000
DTSTAMP:20260418T085941
CREATED:20241009T190246Z
LAST-MODIFIED:20241107T135829Z
UID:10000794-1730898000-1730898000@liferaftgroup.org
SUMMARY:Know Your Mutation:  Why is Biomarker Testing Important in GIST?
DESCRIPTION:The Life Raft Group invites you to “Know Your Mutation: Why is Biomarker Testing Important in GIST?”\, on November 6th\, 2024 at 1PM ET. During this educational webinar\, Michelle Harris and Calvin Chao of Tempus will discuss the importance of biomarker testing in GIST\, the process of biomarker testing\, how to get testing done for free through the LRG\, and more. A Q&A session will follow the presentation. \n\nPlease email srothschild@liferaftgroup.org to submit a question ahead of the presentation.  \n\n\n\nPlease note that this webinar is not a substitute for your physician’s guidance and care.\nREGISTERAbout Our Presenters\n \nDr. Calvin Chao\nSenior Vice President of Medical Affairs\, Tempus \nPreviously\, Dr. Chao spent thirteen years leading studies and education for the Oncotype DX Breast\, Prostate\, and Colon Cancer assays at Genomic Health\, later acquired by Exact Sciences.  Prior to that role\, he worked in various bio-pharmaceutical medical director positions at Onyx Pharmaceuticals\, PDL BioPharma\, TAP Pharmaceuticals\, and SmithKline Beecham. \nIn his early career\, Dr. Chao practiced as a board-certified internist and hospitalist at Kaiser Permanente in California for ten years. He earned his MD from the University of Texas Medical Branch\, completed his medical residency at Presbyterian-St. Luke’s Medical Center in Denver\, Colorado\, received his MBA from St. Mary’s College\, California\, and his BS in Chemical Engineering from University of California\, Berkeley. \n \nMichelle Harris\nSenior Director Medical Affairs\, Tempus AI \nMichelle has worked in the oncology space for almost 20 years in research\, development and medical affairs.  She has been at Tempus AI for 2&1/2 years leading the field medical liaison team\, who work with physicians on research and education.  Prior to Tempus\, Michelle worked in solid tumor drug development and clinical trials at Novartis and Gilead Sciences. \nThank you to our Webinar Sponsors!
URL:https://liferaftgroup.org/event/know-your-mutation/
CATEGORIES:Education,Events,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241125T120000
DTEND;TZID=America/New_York:20241125T120000
DTSTAMP:20260418T085942
CREATED:20241009T202805Z
LAST-MODIFIED:20241120T145456Z
UID:10000795-1732536000-1732536000@liferaftgroup.org
SUMMARY:Updates from CTOS
DESCRIPTION:The Life Raft Group is partnering with Dr. Thierry Alcindor of Dana-Farber Cancer Institute to present “GIST Updates from CTOS 2024” to GIST patients and caregivers on November 25th at 12pm ET. During this virtual presentation\, Dr. Alcindor will discuss scientific updates relevant to GIST patients that were exhibited at the Connective Tissue Oncology Society (CTOS) conference. A Q&A segment followed Dr. Alcindor’s presentation. \n\nPlease email srothschild@liferaftgroup.org to submit a question ahead of the presentation.  \n\n\n\nPlease note that this webinar is not a substitute for your physician’s guidance and care.\nREGISTERAbout Our Presenter\n \nDr. Thierry Alcindor\nDana-Farber Cancer Institute \nDr. Alcindor earned his medical degree at the State University of Haiti and a Master of Science degree at the University of Oxford. He trained in Internal Medicine and Hematology/Oncology at Yale-New Haven Medical Center and Tufts-New England Medical Center\, respectively. Previously at McGill University\, he is now a Senior Physician and medical oncologist at the Dana-Farber Cancer Institute\, affiliated with Harvard Medical School. His interests cover treatment and investigation of sarcomas\, including gastro-intestinal stromal tumors (GIST). \nThank you to our Webinar Sponsors!
URL:https://liferaftgroup.org/event/updates-from-ctos/
CATEGORIES:Education,Events,Webcast
ORGANIZER;CN="Sara Rothschild":MAILTO:srothschild@liferaftgroup.org
END:VEVENT
END:VCALENDAR